VIR vs. CHRW
VIR (Vir Biotechnology, Inc.) and CHRW (C.H. Robinson Worldwide, Inc.) are both stocks. VIR operates in Biotechnology (Healthcare), while CHRW operates in Integrated Freight & Logistics (Industrials). Over the past 5 years, VIR returned -27.29%/yr vs 17.34%/yr for CHRW. At a 0.14 correlation, their price movements are largely independent.
Performance
VIR vs. CHRW - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, VIR achieves a 58.71% return, which is significantly higher than CHRW's 17.16% return.
VIR
- 1D
- 4.48%
- 1M
- 4.13%
- YTD
- 58.71%
- 6M
- 59.23%
- 1Y
- 82.98%
- 3Y*
- -26.96%
- 5Y*
- -27.29%
- 10Y*
- —
CHRW
- 1D
- 1.10%
- 1M
- 7.74%
- YTD
- 17.16%
- 6M
- 14.16%
- 1Y
- 105.15%
- 3Y*
- 30.40%
- 5Y*
- 17.34%
- 10Y*
- 12.65%
VIR vs. CHRW - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
VIR Vir Biotechnology, Inc. | 58.71% | -17.85% | -27.04% | -60.25% | -39.55% | 56.35% | 112.96% | -22.14% |
CHRW C.H. Robinson Worldwide, Inc. | 17.16% | 59.01% | 22.89% | -3.10% | -13.09% | 17.22% | 22.95% | -6.66% |
Correlation
The correlation between VIR and CHRW is 0.09, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.09 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.16 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.15 |
Correlation (All Time) Calculated using the full available price history since Oct 11, 2019 | 0.14 |
Fundamentals
VIR:
$1.41B
CHRW:
$22.64B
VIR:
-$3.14
CHRW:
$4.93
VIR:
20.60
CHRW:
1.40
VIR:
1.74
CHRW:
13.28
VIR:
$65.50M
CHRW:
$16.20B
VIR:
$183.11M
CHRW:
$1.03B
VIR:
-$448.10M
CHRW:
$948.77M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
VIR vs. CHRW — Risk / Return Rank
VIR
CHRW
VIR vs. CHRW - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Vir Biotechnology, Inc. (VIR) and C.H. Robinson Worldwide, Inc. (CHRW). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| VIR | CHRW | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.30 | ||
| Sortino ratioReturn per unit of downside risk | -1.26 | ||
| Omega ratioGain probability vs. loss probability | 1.24 | 1.51 | -0.27 |
| Calmar ratioReturn relative to maximum drawdown | 3.00 | 5.27 | -2.27 |
| Martin ratioReturn relative to average drawdown | 6.84 | 13.75 | -6.91 |
Loading charts...
Drawdowns
VIR vs. CHRW - Drawdown Comparison
The maximum VIR drawdown since its inception was -94.85%, which is greater than CHRW's maximum drawdown of -44.54%. Use the drawdown chart below to compare losses from any high point for VIR and CHRW.
Loading charts...
Drawdown Indicators
| VIR | CHRW | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -94.85% | -44.54% | -50.31% |
Max Drawdown (1Y)Largest decline over 1 year | -27.82% | -20.07% | -7.75% |
Max Drawdown (3Y)Largest decline over 3 years | -82.86% | -30.86% | -52.00% |
Max Drawdown (5Y)Largest decline over 5 years | -92.15% | -40.55% | -51.60% |
Max Drawdown (10Y)Largest decline over 10 years | — | -40.55% | — |
Current DrawdownCurrent decline from peak | -88.48% | -6.10% | -82.38% |
Average DrawdownAverage peak-to-trough decline | -67.81% | -12.08% | -55.73% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 12.17% | 7.67% | +4.50% |
Volatility
VIR vs. CHRW - Volatility Comparison
Vir Biotechnology, Inc. (VIR) has a higher volatility of 15.82% compared to C.H. Robinson Worldwide, Inc. (CHRW) at 8.25%. This indicates that VIR's price experiences larger fluctuations and is considered to be riskier than CHRW based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| VIR | CHRW | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 15.82% | 8.25% | +7.57% |
Volatility (6M)Calculated over the trailing 6-month period | 48.64% | 30.09% | +18.55% |
Volatility (1Y)Calculated over the trailing 1-year period | 69.95% | 42.44% | +27.51% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 72.81% | 32.41% | +40.40% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 95.99% | 28.92% | +67.07% |
Dividends
VIR vs. CHRW - Dividend Comparison
VIR has not paid dividends to shareholders, while CHRW's dividend yield for the trailing twelve months is around 1.34%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CHRW C.H. Robinson Worldwide, Inc. | 1.34% | 1.55% | 2.38% | 2.82% | 2.47% | 1.93% | 2.17% | 2.57% | 2.24% | 2.03% | 2.38% | 2.53% |
VIR Vir Biotechnology, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
VIR vs. CHRW - Financials Comparison
This section allows you to compare key financial metrics between Vir Biotechnology, Inc. and C.H. Robinson Worldwide, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
VIR and CHRW have a correlation of 0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
VIR has higher volatility (15.82%) compared to CHRW (8.25%). In terms of maximum drawdown, VIR dropped -94.85% vs CHRW's -44.54%.
CHRW currently has the higher Sharpe Ratio (2.50 vs 1.19), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for VIR and CHRW
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer